|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/48 | |
| A61K 38/21 |
| (11) | Number of the document | 1667708 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03808554.4 |
| Date of filing the European patent application | 2003-12-23 | |
| (97) | Date of publication of the European application | 2006-06-14 |
| (45) | Date of publication and mention of the grant of the patent | 2012-06-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2003/041160 |
| Date | 2003-12-23 |
| (87) | Number | WO 2004/060299 |
| Date | 2004-07-22 |
| (30) | Number | Date | Country code |
| 436020 P | 2002-12-26 | US | |
| 479914 P | 2003-06-20 | US | |
| 479913 P | 2003-06-20 | US |
| (72) |
SAIFER, Mark G., P., US
MARTINEZ, Alexa, L., US
WILLIAMS, David, L., US
SHERMAN, Merry, R., US
|
| (73) |
Mountain View Pharmaceuticals, Inc.,
3475-S Edison Way, Menlo Park, CA 94025-1813,
US
|
| (54) | POLYETHYLENE GLYCOL CONJUGATES OF INTERFERON-BETA-1b WITH ENHANCED IN VITRO BIOLOGICAL POTENCY |
| POLYETHYLENE GLYCOL CONJUGATES OF INTERFERON-BETA-1b WITH ENHANCED IN VITRO BIOLOGICAL POTENCY |